+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Abiraterone"

Prostate Cancer: Update Bulletin - Product Thumbnail Image

Prostate Cancer: Update Bulletin

  • Newsletter
  • May 2024
  • Global
From
Prostate Cancer Drugs Global Market Report 2024 - Product Thumbnail Image

Prostate Cancer Drugs Global Market Report 2024

  • Report
  • November 2023
  • 175 Pages
  • Global
From
Metastatic Prostate Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic Prostate Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 100 Pages
  • Global
From
From
From
From
From
Castrate Resistant Prostate Cancer - Pipeline Insight, 2020 - Product Thumbnail Image

Castrate Resistant Prostate Cancer - Pipeline Insight, 2020

  • Clinical Trials
  • November 2020
  • 40 Pages
  • Global
From
Research Report on China's Bicalutamide Market, 2021-2025 - Product Thumbnail Image

Research Report on China's Bicalutamide Market, 2021-2025

  • Report
  • November 2021
  • 40 Pages
  • China
From
From
Disease Analysis: Prostate Cancer - Product Thumbnail Image

Disease Analysis: Prostate Cancer

  • Report
  • March 2021
  • 94 Pages
  • Global
Drug Overview: Zytiga - Product Thumbnail Image

Drug Overview: Zytiga

  • Drug Pipelines
  • January 2018
  • 21 Pages
  • Global
From
Drug Overview: Yonsa - Product Thumbnail Image

Drug Overview: Yonsa

  • Drug Pipelines
  • January 2018
  • 13 Pages
  • Global
From
Drug Overview: ipatasertib - Product Thumbnail Image

Drug Overview: ipatasertib

  • Drug Pipelines
  • January 2018
  • 16 Pages
  • Global
From
Drug Overview: apalutamide - Product Thumbnail Image

Drug Overview: apalutamide

  • Drug Pipelines
  • January 2018
  • 18 Pages
  • Global
From
Drug Overview: darolutamide - Product Thumbnail Image

Drug Overview: darolutamide

  • Drug Pipelines
  • January 2018
  • 17 Pages
  • Global
From
From
Loading Indicator

Abiraterone is a drug used to treat prostate cancer. It is a type of hormone therapy, which works by blocking the production of testosterone, a hormone that can fuel the growth of prostate cancer cells. Abiraterone is typically used in combination with other treatments, such as chemotherapy or radiation therapy. It is usually prescribed to men with advanced prostate cancer that has spread to other parts of the body. Abiraterone is available in both oral and injectable forms. Abiraterone has been shown to be effective in treating prostate cancer, and is generally well-tolerated by patients. Common side effects include fatigue, joint pain, and hot flashes. Abiraterone is also associated with an increased risk of high blood pressure and fluid retention. Companies in the Abiraterone market include Janssen Pharmaceuticals, Astellas Pharma, and Teva Pharmaceuticals. Show Less Read more